🍽️ Aeromonadaceae bacterium BM0318(Probiotic)

AI Engines For more Details: PerplexityKagi LabsYou

  1. Gut Health: Probiotics like Bacillus amyloliquefaciens can help maintain a healthy balance of gut microflora. They may support digestion, nutrient absorption, and bowel regularity. By promoting the growth of beneficial bacteria in the gut, Bacillus amyloliquefaciens may help alleviate symptoms of digestive disorders such as diarrhea, constipation, and irritable bowel syndrome (IBS).

  2. Immune Support: The gut plays a crucial role in the body's immune system, and maintaining a healthy gut microbiota is essential for immune function. Bacillus amyloliquefaciens may modulate the immune response and enhance the body's ability to defend against infections and diseases. Some research suggests that probiotics like Bacillus amyloliquefaciens may reduce the risk of respiratory infections and improve overall immune function.

  3. Antimicrobial Activity: Bacillus amyloliquefaciens produces antimicrobial compounds that can inhibit the growth of harmful bacteria, fungi, and other pathogens in the gut. By creating an unfavorable environment for pathogenic microorganisms, Bacillus amyloliquefaciens helps protect against gastrointestinal infections and may contribute to overall health.

  4. Anti-inflammatory Effects: Chronic inflammation is associated with various health conditions, including inflammatory bowel disease (IBD), autoimmune disorders, and metabolic syndrome. Probiotics like Bacillus amyloliquefaciens may have anti-inflammatory properties, helping to reduce inflammation in the gut and throughout the body. By modulating immune responses and cytokine production, Bacillus amyloliquefaciens may alleviate symptoms of inflammatory conditions.

  5. Support for Skin Health: Emerging research suggests a link between gut health and skin health. Probiotics like Bacillus amyloliquefaciens may influence the gut-skin axis, promoting skin barrier function and reducing the severity of skin conditions such as acne, eczema, and atopic dermatitis. By modulating inflammation and improving immune function, Bacillus amyloliquefaciens may contribute to healthier skin.

  6. Nutrient Absorption: Bacillus amyloliquefaciens produces enzymes that aid in the breakdown and digestion of carbohydrates, proteins, and fats. By enhancing nutrient absorption in the gut, Bacillus amyloliquefaciens may improve overall nutritional status and support optimal health and vitality.

;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

Data Contradictions β€” Limits of Certainity

Impacted of Aeromonadaceae bacterium BM0318(Probiotic) On Probiotics

Rank Probiotic Impact

Bacteria Impacted by Aeromonadaceae bacterium BM0318(Probiotic)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation

Impact of Aeromonadaceae bacterium BM0318(Probiotic) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.